| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
1,603 |
1,494 |
$0.00 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
298 |
252 |
$0.00 |
| 99442 |
|
1,072 |
970 |
$0.00 |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
151 |
149 |
$0.00 |
| 90461 |
|
25 |
25 |
$0.00 |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
146 |
141 |
$0.00 |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
221 |
220 |
$0.00 |
| 80061 |
Lipid panel |
479 |
478 |
$0.00 |
| D0220 |
Intraoral - periapical first radiographic image |
29 |
29 |
$0.00 |
| D1120 |
Prophylaxis - child |
30 |
30 |
$0.00 |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
131 |
130 |
$0.00 |
| D0350 |
|
29 |
29 |
$0.00 |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
26 |
25 |
$0.00 |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
30 |
24 |
$0.00 |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
12 |
12 |
$0.00 |
| 4450F |
|
102 |
100 |
$0.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
40 |
40 |
$0.00 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
420 |
417 |
$0.00 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
413 |
407 |
$0.00 |
| D0150 |
Comprehensive oral evaluation - new or established patient |
30 |
30 |
$0.00 |
| 99441 |
|
373 |
326 |
$0.00 |
| 80053 |
Comprehensive metabolic panel |
396 |
388 |
$0.00 |
| 36415 |
Collection of venous blood by venipuncture |
1,330 |
1,280 |
$0.00 |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
745 |
705 |
$0.00 |
| 85027 |
|
404 |
404 |
$0.00 |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
31 |
31 |
$0.00 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
84 |
84 |
$0.00 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
127 |
126 |
$0.00 |
| 85008 |
|
28 |
28 |
$0.00 |
| 90686 |
|
56 |
56 |
$0.00 |
| 84443 |
Thyroid stimulating hormone (TSH) |
12 |
12 |
$0.00 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
29 |
27 |
$0.00 |
| 99443 |
|
171 |
165 |
$0.00 |
| D1330 |
|
30 |
30 |
$0.00 |
| 70300 |
|
32 |
32 |
$0.00 |
| 92551 |
|
14 |
13 |
$0.00 |
| D0230 |
Intraoral - periapical each additional radiographic image |
28 |
28 |
$0.00 |